IL79934A - 8-(substituted benzyl)-1,3,7-trisubstituted xanthine derivatives,their production and pharmaceutical compositions containing them - Google Patents

8-(substituted benzyl)-1,3,7-trisubstituted xanthine derivatives,their production and pharmaceutical compositions containing them

Info

Publication number
IL79934A
IL79934A IL79934A IL7993486A IL79934A IL 79934 A IL79934 A IL 79934A IL 79934 A IL79934 A IL 79934A IL 7993486 A IL7993486 A IL 7993486A IL 79934 A IL79934 A IL 79934A
Authority
IL
Israel
Prior art keywords
production
pharmaceutical compositions
compositions containing
substituted benzyl
xanthine derivatives
Prior art date
Application number
IL79934A
Other languages
English (en)
Other versions
IL79934A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858522096A external-priority patent/GB8522096D0/en
Priority claimed from GB858526504A external-priority patent/GB8526504D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL79934A0 publication Critical patent/IL79934A0/xx
Publication of IL79934A publication Critical patent/IL79934A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/12—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL79934A 1985-09-05 1986-09-03 8-(substituted benzyl)-1,3,7-trisubstituted xanthine derivatives,their production and pharmaceutical compositions containing them IL79934A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858522096A GB8522096D0 (en) 1985-09-05 1985-09-05 Organic compounds
GB858526504A GB8526504D0 (en) 1985-10-28 1985-10-28 Organic compounds

Publications (2)

Publication Number Publication Date
IL79934A0 IL79934A0 (en) 1986-12-31
IL79934A true IL79934A (en) 1990-06-10

Family

ID=26289737

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79934A IL79934A (en) 1985-09-05 1986-09-03 8-(substituted benzyl)-1,3,7-trisubstituted xanthine derivatives,their production and pharmaceutical compositions containing them

Country Status (15)

Country Link
EP (1) EP0215736B1 (el)
JP (1) JPH0692406B2 (el)
KR (1) KR900008569B1 (el)
AU (1) AU594363B2 (el)
CA (1) CA1266470A (el)
DE (1) DE3673734D1 (el)
DK (1) DK422086A (el)
ES (1) ES2001944A6 (el)
FI (1) FI863550A (el)
GR (1) GR862252B (el)
HU (1) HU197746B (el)
IL (1) IL79934A (el)
NZ (1) NZ217448A (el)
PL (1) PL149932B1 (el)
PT (1) PT83305B (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2033922T3 (es) * 1986-08-28 1993-04-01 Sandoz Ag Procedimiento para preparar nuevos derivados de xantina.
JP2843634B2 (ja) * 1989-03-06 1999-01-06 協和醗酵工業株式会社 キサンチン誘導体
US5208240A (en) * 1991-03-12 1993-05-04 Merrell Dow Pharmaceuticals Inc. 8-substituted purines as selective adenosine receptor agents
DE4129603A1 (de) * 1991-09-06 1993-03-11 Thomae Gmbh Dr K Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
AU6781194A (en) * 1993-05-03 1994-11-21 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
GB0005199D0 (en) * 2000-03-04 2000-04-26 Imp College Innovations Ltd Modulation of histone deacetylase
JP2006329451A (ja) * 2005-05-23 2006-12-07 Sanoh Industrial Co Ltd 熱交換器用伝熱管

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1076683B (de) * 1958-12-16 1960-03-03 Schering Ag Verfahren zur Herstellung der Ameisensaeureester von 1-Alkinylcycloalkanolen
FR2531085A1 (fr) * 1982-07-28 1984-02-03 Adir Nouveaux derives de la xanthine, leur procede de preparation et les compositions pharmaceutiques les renfermant
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same

Also Published As

Publication number Publication date
KR870003107A (ko) 1987-04-15
KR900008569B1 (ko) 1990-11-24
FI863550A (fi) 1987-03-06
EP0215736A1 (en) 1987-03-25
IL79934A0 (en) 1986-12-31
DK422086D0 (da) 1986-09-03
ES2001944A6 (es) 1988-07-01
GR862252B (en) 1986-12-31
DK422086A (da) 1987-03-06
HUT44552A (en) 1988-03-28
FI863550A0 (fi) 1986-09-03
EP0215736B1 (en) 1990-08-29
AU594363B2 (en) 1990-03-08
NZ217448A (en) 1989-10-27
DE3673734D1 (de) 1990-10-04
JPS6263585A (ja) 1987-03-20
PT83305A (en) 1986-10-01
CA1266470A (en) 1990-03-06
AU6230786A (en) 1987-03-12
PL149932B1 (en) 1990-04-30
PT83305B (pt) 1989-05-12
HU197746B (en) 1989-05-29
PL261284A1 (en) 1988-07-21
JPH0692406B2 (ja) 1994-11-16

Similar Documents

Publication Publication Date Title
IL83659A (en) 8-(substituted benzylamino)-1,3,7-trisubstituted xanthine derivatives,their production and pharmaceutical compositions containing them
IL78605A (en) 8-(substituted phenyl)xanthine derivatives,their preparation and pharmaceutical compositions containing them
NZ216021A (en) Purine and 1,2,3 triazolopyrimidine derivatives and pharmaceutical compositions
NZ223694A (en) Heterocyclically substituted piperazine derivatives and pharmaceutical compositions
ZA877530B (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same as well as processes for production thereof
NZ225906A (en) Aristeromycin/adenosine derivatives and pharmaceutical compositions
NZ213798A (en) Guanine derivatives and pharmaceutical compositions
NZ217220A (en) Guanine derivatives and pharmaceutical compositions
IL79934A (en) 8-(substituted benzyl)-1,3,7-trisubstituted xanthine derivatives,their production and pharmaceutical compositions containing them
NZ212060A (en) Bicyclic hetrocycles and pharmaceutical derivatives
IL88138A0 (en) Purine derivatives,their preparation and pharmaceutical compositions containing them
IL80109A0 (en) 6,9-substituted purines,pharmaceutical compositions containing them and processes for their preparation
ZA855399B (en) Use of xanthine and thioxanthine derivatives for the preparation of medicaments
NZ219250A (en) Purine derivatives and pharmaceutical compositions
GB2170407B (en) Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions
IL84728A (en) Bicyclic v-triazine-4-one derivatives,their manufacture and pharmaceutical compositions containing them
IL74803A0 (en) Purine derivatives,their preparation and pharmaceutical compositions containing them
ZA855937B (en) Imidazo 1,2-a quinoline derivatives,their preparation and pharmaceutical compositions containing them
IL76242A0 (en) Saframycin a derivatives,their preparation and pharmaceutical compositions containing them
NZ225509A (en) Nitrogen-containing bicyclic derivatives and pharmaceutical compositions
IL88854A (en) Pyrimidine and purine 1,2-butadiene-4-ol derivatives and pharmaceutical compositions containing the same
IL70651A (en) 7-(2-arylethenyl)-5-oxo-5h-thiazolo(3,2-a)pyrimidine-2-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL92139A0 (en) Penicillanic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL89063A0 (en) Ergoline derivatives,their production and pharmaceutical compositions containing them
NZ226785A (en) Isoxazolo(4,5-c azepine derivatives and pharmaceutical compositions